The Faculty of Pharmaceutical Sciences is an effective research unit within the University of Iceland, where diverse research is carried out in the various fields of pharmaceutical sciences.Research is carried out in collaboration with numerous parties domestically and abroad, including universities, research institutes and companies. Lecturers in pharmaceutical sciences are members of Nordic and European teaching and research networks, ensuring important international relations, and allowing students to take part of their studies abroad. All lecturers at the Faculty of Pharmaceutical Sciences are active research in their respective fields, and their participation in the international scientific and research community has grown considerably in recent years. In Iceland, lecturers at the faculty have hosted and organised international conferences, including those deal with the chemistry of cyklodextrins, clinical pharmaceutical research and mucus membrane-immunity studies, chemometrics and chemical engineering in pharmaceutical development. With active research and teaching in pharmaceutical sciences, the faculty contributes to knowledge creation in Icelandic society in the fields of health and life sciences. Research training in the field of pharmaceutical sciences is not only useful for traditional pharmaceutical research, but also as part of a larger research community in the health sciences. With growing collaboration and cooperation, more complicated and broad projects can be tackled than ever before. Lectures´ respective fields Anna Bryndís Blöndal Anna Bryndís Blöndal: Research in clinical pharmacy (e.g., pharmaceutical care, polypharmacy, and drug-related problems), social pharmacy, and service development. Additionally, good knowledge of qualitative research methods and action research. Berglind Eva Benediktsdóttir Berglind Eva Benediktsdóttir: Main topics of interest are extracellular vesicles (EVs), both as nanocarriers for active pharmaceutical ingredients (APIs) but also to investigate the role of EVs in various disease progression. Research interest is also in pharmacology of cancer therapeutics and permeation of APIs through epithelial cell membranes. Elvar Örn Viktorsson Elvar Örn Viktorsson: The primary focus of research is within the field of medicinal chemistry. Development of natural products, more specifically bioactive phenazines to target cancerous diseases and harmful microorganisms. Freyja Jónsdóttir Freyja Jónsdóttir: Clinical pharmacy, polypharmacy, medication-related harm, potentially inappropriate prescribing among older patients, medication adherance, pharmacoepidemiology Haraldur Gunnar Guðmundsson Haraldur Gunnar Guðmundsson: My research focuses on the development of novel methods for the introduction of isotope tracers and their application in the preparation of isotopologues of pharmaceuticals and other bioactive compounds of interest. Hákon Hrafn Sigurðsson Hákon Hrafn Sigurðsson: Topical drug delivery systems (ocular and skin). Cyclodextrins as pharmaceutical excipients. Drug transport in mucus membranes. Helga Helgadóttir Helga Helgadóttir: 1. Pregnancy-related diseases, with special emphasis on preeclampsia and other hypertension-related problems during pregnancy. 2. Development of pharmaceutical dosage forms, in particular topical forms. 3. Research related to Raman Spectroscpy Lárus Steinþór Guðmundsson Lárus Steinþór Guðmundsson: Epidemiology of headache, migraine and co-morbid conditions. Drug utilization studies, pharmacoepidemiology. Long-term use of hypnotics, sedatives and opioids in relation to multimorbidity and mortality. Margrét Þorsteinsdóttir Margrét Þorsteinsdóttir: The main research area is the development of analytical methods for metabolite profiling, targeted proteomics and quantification of clinical biomarkers in various biofluids with mass spectrometry. My focus has been on implementation of clinical mass spectrometry for improved diagnosis and pharmacotherapy monitoring of patients with various diseases. I am also interested in developing mass spectrometry methods for identification of bioactive compounds of natural origin. Már Másson Már Másson: In his research, Már Másson has emphasized the synthesis of derivatives of chitosan, which is a biopolymer obtained from shrimp shells. Chitosan derivatives have been used in the development of nanomedicines against infections and cancer. The research involves the development of chemical synthesis methods, characterization of compounds, and investigations into antimicrobial and antifungal effects, nanoparticles, bioactive compounds, and bioactive coatings. In addition, Már's research group has studied drug delivery from medical devices made of silicone and other materials and worked on mathematical modeling. Páll Þór Ingvarsson Páll Þór Ingvarsson: Development of spray drying processes and dry powder formulations of protein/peptide/small-molecules for increased stability and engineered particle properties. Sveinbjörn Gizurarson Sveinbjörn Gizurarson: Rannsóknarsvið:1. Development of emergency drugs for acute treatments with rapid onset. 2. Vaccinations and formulations for vaccines3. Clinical pharmacokinetics and toxicology4. Maternal, fetal and pediatric drug delivery5. Neglected Tropical Diseases Þorsteinn Loftsson Þorsteinn Loftsson: Formulation design, pharmacokinetics, ophthalmic drug delivery, and pharmaceutical applications of cyclodextrins. facebooklinkedintwitter
